We know of 7 out of the 30 sits or about 23% of the sites participating in the study...
pps = .23

Maybe when we get up to 15 sites or 50% of participating in the study the pps will be .50 and so on...


"The ACORD (Angiogenesis for the treatment of CORonary heart Disease) trial will include four randomized, double-blind, placebo-controlled doses in approximately 120 patients with severe coronary heart disease. Thirty sites are expected to participate. The clinical research organization, Kendle, is overseeing and managing our Phase II trial."